- In July 2024, Viromed Medical AG initiated a second groundbreaking study to explore the use of cold plasma in preventing ventilator-associated pneumonia (VAP). The study, aims to secure expedited special approval for the PulmoPlas device, developed by Viromed, for this innovative preventive treatment in Germany and the USA
